Next Article in Journal
A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus
Next Article in Special Issue
Presence of a Novel Subtype of Bovine Hepacivirus in China and Expanded Classification of Bovine Hepacivirus Strains Worldwide into 7 Subtypes
Previous Article in Journal
Erythroid Progenitor Cells in Atlantic Salmon (Salmo salar) May Be Persistently and Productively Infected with Piscine Orthoreovirus (PRV)
Previous Article in Special Issue
Faecal Virome Analysis of Wild Animals from Brazil
Brief Report

A Fusion Peptide in the Spike Protein of MERS Coronavirus

School of Biological Sciences, University of Reading, Reading RG6 6AJ, UK
Biology Department, CASE, Texas A&M University, Texarkana, TX 75503, USA
Author to whom correspondence should be addressed.
Viruses 2019, 11(9), 825;
Received: 22 July 2019 / Revised: 27 August 2019 / Accepted: 29 August 2019 / Published: 5 September 2019
(This article belongs to the Special Issue Emerging Viruses: Surveillance, Prevention, Evolution and Control)
Coronaviruses represent current and emerging threats for many species, including humans. Middle East respiratory syndrome-related coronavirus (MERS-CoV) is responsible for sporadic infections in mostly Middle Eastern countries, with occasional transfer elsewhere. A key step in the MERS-CoV replication cycle is the fusion of the virus and host cell membranes mediated by the virus spike protein, S. The location of the fusion peptide within the MERS S protein has not been precisely mapped. We used isolated peptides and giant unilamellar vesicles (GUV) to demonstrate membrane binding for a peptide located near the N-terminus of the S2 domain. Key residues required for activity were mapped by amino acid replacement and their relevance in vitro tested by their introduction into recombinant MERS S protein expressed in mammalian cells. Mutations preventing membrane binding in vitro also abolished S-mediated syncytium formation consistent with the identified peptide acting as the fusion peptide for the S protein of MERS-CoV. View Full-Text
Keywords: coronavirus; MERS; spike protein; peptide; membrane; fusion assay coronavirus; MERS; spike protein; peptide; membrane; fusion assay
Show Figures

Figure 1

MDPI and ACS Style

Alsaadi, E.A.J.; Neuman, B.W.; Jones, I.M. A Fusion Peptide in the Spike Protein of MERS Coronavirus. Viruses 2019, 11, 825.

AMA Style

Alsaadi EAJ, Neuman BW, Jones IM. A Fusion Peptide in the Spike Protein of MERS Coronavirus. Viruses. 2019; 11(9):825.

Chicago/Turabian Style

Alsaadi, Entedar A.J., Benjamin W. Neuman, and Ian M. Jones. 2019. "A Fusion Peptide in the Spike Protein of MERS Coronavirus" Viruses 11, no. 9: 825.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop